| Customization: | Available |
|---|---|
| CAS No.: | 363-24-6 |
| Formula: | C20h32o5 |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Prostaglandin E2 |
| CAS number | 363-24-6 |
| Molecular formula | C20H32O5 |
| Molecular weight | 352.47 |
| Appearance | White powder |
| Purity | 99.0% |
| Packge | 10gram, 100gram, 1KG or under requirement |
| Description | Victoza is FDA-approved for type 2 diabetes mellitus (DM) and prophylaxis for disorder of cardiovascular system as a result of type 2 diabetes. Its dosing involves titration to reduce gastrointestinal symptoms, such as nausea, diarrhea, and vomiting: initiate 0.6 mg daily subcutaneous injection for 1 week; increase to maintenance dose of 1.2 mg daily; and increase to 1.8 mg daily, as needed. Liraglutide is also FDA-approved as Saxenda for obesity with a body mass index of 30kg/m2< or 27kg/m2 with the presence of at least 1 weight-related comorbid condition. Saxenda is initiated at 0.6 mg subcutaneous daily injection for 1 week, with weekly increments of 0.6 mg per day, until the maintenance dosage of 3 mg once daily is reached.3 If the patient misses a dose of liraglutide injection for more than 3 days, re-initiation at 0.6 mg is recommended to mitigate gastrointestinal (GI) symptoms. |
){kind=link}